Enhanced A₃adenosine receptor selectivity of multivalent nucleoside-dendrimer conjugates

• Main Authors: Shainberg Asher, Lloyd John, Gao Zhan-Guo, Klutz Athena M, Jacobson Kenneth A
• Format: Article
• Language: English
• Published: BMC 2008-10-01
• Series: Journal of Nanobiotechnology
• Online Access: http://www.jnanobiotechnology.com/content/6/1/12

<p>Abstract</p> <p>Background</p> <p>An approach to use multivalent dendrimer carriers for delivery of nucleoside signaling molecules to their cell surface G protein-coupled receptors (GPCRs) was recently introduced.</p> <p>Results</p> <p>A known adenosine receptor (AR) agonist was conjugated to polyamidoamine (PAMAM) dendrimer carriers for delivery of the intact covalent conjugate to on the cell surface. Depending on the linking moiety, multivalent conjugates of the <it>N</it>⁶-chain elongated functionalized congener ADAC (<it>N</it>⁶-[4-[[[4-[[[(2-aminoethyl)amino]carbonyl]methyl]anilino]carbonyl]methyl]phenyl]-adenosine) achieved unanticipated high selectivity in binding to the cytoprotective human A₃AR, a class A GPCR. The key to this selectivity of > 100-fold in both radioreceptor binding (K_{i app}= 2.4 nM) and functional assays (EC₅₀= 1.6 nM in inhibition of adenylate cyclase) was maintaining a free amino group (secondary) in an amide-linked chain. Attachment of neutral amide-linked chains or thiourea-containing chains preserved the moderate affinity and efficacy at the A₁AR subtype, but there was no selectivity for the A₃AR. Since residual amino groups on dendrimers are associated with cytotoxicity, the unreacted terminal positions of this A₃AR-selective G2.5 dendrimer were present as carboxylate groups, which had the further benefit of increasing water-solubility. The A₃AR selective G2.5 dendrimer was also visualized binding the membrane of cells expressing the A₃receptor but did not bind cells that did not express the receptor.</p> <p>Conclusion</p> <p>This is the first example showing that it is feasible to modulate and even enhance the pharmacological profile of a ligand of a GPCR based on conjugation to a nanocarrier and the precise structure of the linking group, which was designed to interact with distal extracellular regions of the 7 transmembrane-spanning receptor. This ligand tool can now be used in pharmacological models of tissue rescue from ischemia and to probe the existence of A₃AR dimers.</p>